source
- FDA shelves fast-track drug review program launched in 2025The U.S. Food and Drug Administration announced it is suspending the fast-track drug review initiative that was introduced in June 2025 under former commissioner Marty Makary. The program, called…
- BMS to consolidate R&D under single leader as chief research officer exitsBristol Myers Squibb announced a reorganization of its research and development unit, merging early research and discovery with drug development under a single leader. Chief Research Officer Rober…